Brought to you by 
BioInvent International nets $25.5mm with IPO in Sweden
01 Apr 2002
Executive Summary
BioInvent International (antibody technology) floated its IPO on the Stockholm Exchange and grossed $25.5mm (SEK261.6mm) in a 2.5 oversubscribed offering of 4.5mm common shares at $5.70 (SEK62) each. When it filed in May, the company was looking to raise between $26mm (SEK270mm) and $33mm (SEK338mm).
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Large Molecule
- Antibodies
-
Drug Discovery Tools
- Genomics-Proteomics
-
Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
BioInvent International nets $25.5mm with IPO in Sweden
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice